| Accession |
PRJCA017192 |
| Title |
Single-center, randomized, double-blind, placebo-controlled, single-dose and multi-dose phase I clinical trials |
| Relevance |
Medical |
| Data types |
Clinical ,metabolome,biomarker and safety data
|
| Organisms |
Homo sapiens
|
| Description |
The project is Phase I,Randomized,Double-blind,Placebo-controlled,Single and Multiple-dose Study enrolled 90 healthy subjects and 10 obese subjects, 60 type 2 diabetic subjects to evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of HEC88473 injection of Single and Multiple-dose. |
| Sample scope |
Metabolome Data and Clinical information |
| Release date |
2023-06-09 |
| Grants |
| Agency |
program |
Grant ID |
Grant title |
| Dongguan HEC Biopharmaceutical R&D Co., Ltd.
|
|
NA
|
|
|
|
| Submitter |
Yanhua
Ding (18343115092@163.com)
|
| Organization |
The First Hospital of Jilin University |
| Submission date |
2023-05-23 |
